Celularity CEO Comments on Centers for Medicare & Medicaid Services Withdrawal of Skin Substitute Local Coverage Determinations
While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage…
Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support
LAS VEGAS, Dec. 24, 2025 (GLOBE NEWSWIRE) -- This holiday season, addiction…
Profound Medical Corp. Announces Upsize of Private Placement
TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN)…
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
December 24, 2025 16:00 ET | Source: XTL Biopharmaceuticals Ltd. RAMAT GAN,…
How Two Women Are Working to Modernize India’s Radiology Systems
CHENNAI, India, Dec. 24, 2025 /PRNewswire/ -- Every medical diagnosis is built…
3 in 4 Asia Pacific Entrepreneurs Anticipate Economic Gains Next Year – Herbalife Survey
HONG KONG, Dec. 17, 2025 /PRNewswire/ -- Herbalife, a premier health and…
Best Peptides for Muscle Growth: Prescription Sermorelin Access, Injectable vs. Dissolving Tablets, and Realistic Expectations
AUSTIN, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for…
U.S. FDA Approves Agios AQVESME (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and…
TraceLink Wins 2025 Merit Award — Recognized for Healthcare Innovation for the Third Consecutive Year
TraceLink has been named a winner of the 2025 Merit Awards for…
Clinikk Secures IRDAI Approval, Expands with Three New Health Hubs, and Launches its Diamond OPD Membership
BENGALURU, India, Dec. 17, 2025 /PRNewswire/ -- Healthtech company Clinikk, building India's…